GLP-1 drugs , or glucagon-like peptide-1 receptor agonists , represent a truly innovation in how we approach diabetes mellitus . These new drugs work by stimulating the body’s inherent GLP-1 substance , https://digibookmarks.com/story21678869/glp-1-a-significant-advance-in-glucose-care